We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
Cap. Flow
-$1.56B
Cap. Flow %
-3.42%
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$352M
2
KR icon
Kroger
KR
+$279M
3
T icon
AT&T
T
+$235M
4
INTC icon
Intel
INTC
+$217M
5
EW icon
Edwards Lifesciences
EW
+$212M

Sector Composition

Rank Sector Weight
1 Financials 19.08%
2 Technology 16.14%
3 Healthcare 15.45%
4 Consumer Discretionary 9.74%
5 Consumer Staples 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFS icon
2776
Intercorp Financial Services
IFS
$6.29B
$422K ﹤0.01%
21,096
+11,044
+110% +$251K
RGTI icon
2777
Rigetti Computing
RGTI
$4.39B
$421K ﹤0.01%
+223,801
New +$838K
CAAP icon
2778
Corporacion America
CAAP
$4.17B
$420K ﹤0.01%
+63,321
New +$378K
OLN icon
2779
Olin
OLN
$2.53B
$418K ﹤0.01%
+9,746
New +$494K
BBAI.WS icon
2780
CALL
BigBear.ai Holdings Warrant
BBAI.WS
$49.2M
$416K ﹤0.01%
265,518
-154,439
-37% -$29.4K
LILA icon
2781
Liberty Latin America Class A
LILA
$1.72B
$416K ﹤0.01%
98,811
-139,883
-59% -$676K
VC icon
2782
Visteon
VC
$2.85B
$416K ﹤0.01%
3,925
-4,710
-55% -$562K
NTLA icon
2783
Intellia Therapeutics
NTLA
$1.51B
$414K ﹤0.01%
7,400
-2,724
-27% -$169K
FBT icon
2784
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.84B
$410K ﹤0.01%
+3,100
New +$435K
FMAO icon
2785
Farmers & Merchants Bancorp
FMAO
$483M
$410K ﹤0.01%
+15,233
New +$454K
LIAN
2786
DELISTED
LianBio American Depositary Shares
LIAN
$410K ﹤0.01%
206,497
-16,894
-8% -$40.4K
SLVR
2787
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
$409K ﹤0.01%
41,988
AGIO icon
2788
Agios Pharmaceuticals
AGIO
$2.08B
$408K ﹤0.01%
14,413
-29,150
-67% -$782K
NGVC icon
2789
Vitamin Cottage Natural Grocers
NGVC
$760M
$408K ﹤0.01%
+37,762
New +$561K
RAD
2790
DELISTED
Rite Aid Corporation
RAD
$408K ﹤0.01%
+82,434
New +$640K
ADVWW
2791
CALL
DELISTED
Advantage Solutions Warrant
ADVWW
$407K ﹤0.01%
190,825
+39,736
+26% +$12.6K
HACK icon
2792
Amplify Cybersecurity ETF
HACK
$2.6B
$407K ﹤0.01%
9,397
-17,225
-65% -$822K
OLMA icon
2793
Olema Pharmaceuticals
OLMA
$977M
$404K ﹤0.01%
146,834
+9,368
+7% +$39.7K
PIIIW icon
2794
CALL
P3 Health Partners Inc Warrant
PIIIW
$126K
$404K ﹤0.01%
87,368
GP
2795
GreenPower Motor Co
GP
$10.5M
$403K ﹤0.01%
17,299
+14,355
+488% +$454K
BODY.WS
2796
CALL
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$403K ﹤0.01%
400,000
OPFI.WS
2797
CALL
DELISTED
OppFi Inc Warrants
OPFI.WS
$402K ﹤0.01%
175,000
ICU icon
2798
SeaStar Medical
ICU
$13M
$401K ﹤0.01%
156
LCNB icon
2799
LCNB Corp
LCNB
$289M
$400K ﹤0.01%
+25,190
New +$389K
THCPW
2800
CALL
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$400K ﹤0.01%
41,026

Similar funds

Marshall Wace's Q3 2022 Portfolio in Review

As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.

  • Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
  • Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
  • Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
  • Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
  • Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
  • Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
  • Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.